|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL ARTICLE |
1 Department of Pathology, CROL, SA, Lisbon, Portugal
2 Cytogenetic Laboratory of Molecular Pathobiology Research Centre (CIPM) of Portuguese Cancer Institute, CROL, SA, Lisbon
Correspondence to:
Dr António E Pinto
Departamento de Patologia Morfológica, Instituto Português de Oncologia, CROL, SA, R Prof Lima Basto, 1099-023 Lisbon, Portugal; aepinto{at}ipolisboa.min-saude.pt
Objective: To investigate underlying genetic events associated with complex DNA ploidy breast carcinomas.
Methods: Screening for chromosome imbalances was carried out using comparative genomic hybridisation (CGH) in 14 frozen samples of tumour from a series of 13 breast cancer patients with multiploid (n = 11) and hypertetraploid (n = 2) tumours. They had previously been analysed by DNA flow cytometry and also assessed immunohistochemically for p53 tissue expression. Ploidy status was determined on frozen samples using the Multicycle software program.
Results: The total number of copy gains (n = 242) was significantly greater than the number of copy losses (n = 51). The mean (SD) number of gains per sample was 17.3 (5.7), and of losses, 3.6 (4.2) (p = 0.0001). Gains of chromosomal regions at 1q (14/14; 100%), 7q (12/14; 85.7%), and 3q (11/14; 78.6%), as well as 1p, 2q, 5p, 8q, and 13q (10/14; 71.4%) were the most frequent aberrations in this series. Losses were most commonly found on 17p (5/14; 35.7%). Three patients dying of the disease had tumours with high level amplifications at 1q12-qter, 3q22q25, and 8q22q23 regions. Six cases had p53 overexpression, of whom four showed 12q gains and two showed 17p losses.
Conclusions: There is a very high incidence of genetic aberrations, mainly related to chromosomal gains, in this subgroup of aneuploid breast cancer patients, associated with a poor clinical outcome. The 7q locus, not previously reported as showing frequent changes in breast cancer, was found to be a potential site for some candidate oncogenes.
Abbreviations: CGH, comparative genomic hybridisation; DI, DNA index; FCM, flow cytometry; TNM, "tumour, node, metastasis" classification; UICC, International Union Against Cancer
Keywords: breast cancer; DNA flow cytometry; comparative genomic hybridisation; multiploid/hypertetraploid tumours
This article has been cited by other articles:
![]() |
K. Savage, M. B.K. Lambros, D. Robertson, R. L. Jones, C. Jones, A. Mackay, M. James, J. L. Hornick, E. M. Pereira, F. Milanezi, et al. Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis Clin. Cancer Res., January 1, 2007; 13(1): 90 - 101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |